Concepedia

Publication | Open Access

DACT2 protects against pulmonary fibrosis via suppressing glycolysis in lung myofibroblasts

13

Citations

20

References

2022

Year

Abstract

In conclusion, our findings support for DACT2 as a novel pharmacological target for pulmonary fibrosis treatments.

References

YearCitations

Page 1